MRD Tests May Speed Myeloma Tx Approvals

A panel of US government advisers unanimously supported the use of highly sensitive tests to detect minimal residual disease in multiple myeloma patients to speed up drug approvals. The FDA is not required to follow this recommendation but often does. Panelists emphasized the importance of confirmatory studies to validate findings based on MRD data. Researchers…

Read More

Want to Connect with Innovative Healthcare Startups and Investors? Register for MedCity INVEST Today!

MedCity INVEST is an annual conference that brings together investors and startups in the healthcare industry. The conference will cover various topics such as healthcare transformation, government funding for startups, and networking opportunities. Speakers include industry experts from organizations such as GE Healthcare, Blue Shield of California, and the National Institutes of Health. The conference…

Read More

Hybrid behavioral health provider Two Chairs scores $72M

Two Chairs, a behavioral health company in California, raised $72 million in a Series C funding round led by Amplo Financing. The company matches patients with therapists through a 45-minute interview process with licensed experts. They offer therapy in person and virtually, with clinics in California, Washington, and Florida. Two Chairs is expanding to more…

Read More

Paris Hilton Backs California Bill Requiring Sunshine on ‘Troubled Teen Industry’

Celebrity Paris Hilton is supporting California lawmakers in pushing for more transparency in teen therapeutic centers by requiring reporting on the use of restraints and seclusion rooms. Hilton, who has been an advocate against the troubled teen industry, testified in front of the Senate Human Services Committee. The proposed Accountability in Children’s Treatment Act aims…

Read More

ESC scoring tool predicts survival in SSc-associated pulmonary arterial hypertension

The 2022 European Society of Cardiology risk assessment tool accurately predicts survival in patients with systemic sclerosis-associated pulmonary arterial hypertension. The tool, based on WHO functional class, serum NT-proBNP, and six-minute walk distance, stratifies patients into low, intermediate, and high-risk categories. The study included 260 patients and found that a higher risk score was associated…

Read More

Zepbound effective in obstructive sleep apnea trials

Eli Lilly’s obesity drug Zepbound has shown positive results in treating obstructive sleep apnea, positioning it as a potential first approved treatment for the disorder. In a year-long Phase 3 study, patients with obesity not on PAP therapy experienced a significant reduction in breathing interruptions during sleep while taking Zepbound compared to those on a…

Read More
error: Content is protected !!